Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Clearside Biomedical, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 26 | −18 |
| SharesConverted for a 1-for-15 split | 625.7K | 6.20K | 552.5K | −67.0K (−10.8%) |
| Value | $7.51M | $74.4K | $2.18M | −$5.25M (−70.6%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Clearside Biomedical, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apollon Wealth Management, LLC | 23,586 | $93.6K | 0.00% |
| New Millennium Group LLC | 2,952 | $11.7K | 0.01% |
| FMR LLC | 83 | $330 | 0.00% |
| Financial Consulate, Inc | 66 | $263 | 0.00% |
| Barclays PLC | 14 | $56 | 0.00% |
| Citigroup Inc | 1 | $4 | 0.00% |
Sold out (24)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
Not filed for Q3 2025 yet (1)
Institutions that held Clearside Biomedical, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Northeast Financial Consultants Inc | 93,000 | $74.4K |